ArticleEvidence-based complementary and alternative medicine : eCAM2022

Evaluation of Annexins Family as Potential Biomarker for Predicting Progression and Prognosis in Clear Renal Cell Carcinoma.

Jiyu Zhao et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.